<DOC>
	<DOCNO>NCT01138059</DOCNO>
	<brief_summary>This study test hypothesis whether patient unclear-onset stroke ( UnCLOS ) treat thrombolysis could achieve prespecified rate good clinical outcome . The secondary hypothesis efficacy outcomes UnCLOS group would superior historical UnCLOS group prospective stroke registry .</brief_summary>
	<brief_title>Reperfusion Therapy Acute Ischemic Stroke With Unclear Onset</brief_title>
	<detailed_description>1 . Study design : A prospective multicenter trial 2 . Study center : 6 participate medical center South Korea 3 . Participants : Consecutive patient acute ischemic stroke visit emergency room within 6 hour detection stroke symptom 4 . Methods - 3 thrombolysis protocol applicable UnCLOS patient 1 . IV tissue plasminogen activator ( tPA ) : Conventional intravenous tPA ( 0.9 mg/kg , 10 % dose bolus remainder 60 minute ) administer patient within 3 hour first find abnormal time arterial occlusion catheter-inaccessible occlusion . 2 . IV tPA + IA urokinase protocol : Combined intravenous tPA ( 0.6 mg/kg , 10 % dose bolus remainder 30 minute ) intra-arterial urokinase administer within 3 hour first find abnormal time catheter-accessible arterial occlusion . 3 . IA UK protocol : Intra-arterial urokinase give 3 6 hour first find abnormal time catheter-accessible arterial occlusion . 5 . Outcome variable - Safety outcomes Symptomatic intracranial hemorrhage ( ICH ) within 48 hour thrombolytic therapy . - Efficacy outcomes 1 . Long-term clinical outcome ( modify Rankin Scale ) 3 month 2 . Secondary efficacy outcome : Good vs. Poor outcome accord mRS responder analysis , Early neurological improvement , Immediate 5-day recanalization MRA CTA</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<criteria>1 . The patient male female age 18 85 year 2 . The patient unclear onset stroke 3 . Treatment patient initiate within 6 hour first find abnormal time 4 . The patient imagingdefined penumbra ( least 20 % ) , measure diffusion perfusionweighted MRI 1 . The patient minor neurologic deficit ( NIHSS &lt; 4 , except aphasia hemianopia ) . 2 . The patient rapidly resolve neurological symptom rate improvement project give patient NIHSS score &lt; 4 time treatment . 3 . The patient prestroke mRS score &gt; 1 ( indicate previous disability ) . 4 . The symptom stroke suggestive subarachnoid hemorrhage . 5 . Evidence infective endocarditis septic embolism 6 . The patient history clinical presentation ICH , SAH , AVM . 7 . Serious head trauma within 6 week 8 . Prior ischemic stroke previous 6 week ( except small infarct ) 9 . Myocardial infarction previous 3 week 10 . Gastrointestinal urinary tract bleed previous 21 day 11 . Major surgery previous 14 day 12 . History biopsy parenchymal organ , trauma internal organ injury lumbar puncture within 14 day 13 . Arterial puncture noncompressible site previous 7 day 14 . Uncontrolled high blood pressure ( systolic &gt; 185 mmHg diastolic &gt; 110 mmHg 3 separate occasion least 10 min apart despite appropriate treatment ) 15 . Evidence active bleed acute trauma ( fracture ) examination 16 . Current use oral anticoagulant prolong prothrombin time ( INR &gt; 1.7 ) 17 . The patient treat heparin previous 48 hour prolong aPTT , except low dose subcutaneous LMWH dos recommend DVT prophylaxis 18 . Baseline platelet count &lt; 100,000 mm3 19 . Baseline hematocrit &lt; 25 % 20 . Blood glucose concentration &lt; 50 mg/dL ( 2.7 mmol/L ) case CT screen 21 . Seizure onset postictal residual neurological impairment case CT screen 22 . The patient terminal illness . 23 . The patient , opinion investigator , unlikely comply clinical study protocol unsuitable reason . 24 . The patient extensive early infarction affect area define infarcted core involve &gt; 1/3 MCA territory entire ACA PCA territory 25 . The patient welldeveloped parenchymal hyperintensity FLAIR , T2* , EPIT2 image , mark hypodensity CT , indicative subacute infarction , enhancement morphologic feature suggest lesion 6 hour old 26 . The patient contraindication image technique ( mean ferromagnetic object MRI , contraindication contrast agent , renal disease iodinate contrast agent perfusion CT CTA , etc . ) 27 . The patient image evidence ICH SAH , AVM , brain tumor ( Incidental meningioma microbleeds exclusion criterion . Incidental unruptured aneurysm small ( &lt; 5mm ) exclusion criterion ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>Acute ischemic stroke unclear onset time</keyword>
</DOC>